201 related articles for article (PubMed ID: 15016427)
61. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Gibson KM; Gupta M; Pearl PL; Tuchman M; Vezina LG; Snead OC; Smit LM; Jakobs C
Biol Psychiatry; 2003 Oct; 54(7):763-8. PubMed ID: 14512218
[TBL] [Abstract][Full Text] [Related]
62. Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).
Chambliss KL; Hinson DD; Trettel F; Malaspina P; Novelletto A; Jakobs C; Gibson KM
Am J Hum Genet; 1998 Aug; 63(2):399-408. PubMed ID: 9683595
[TBL] [Abstract][Full Text] [Related]
63. Succinic semialdehyde dehydrogenase deficiency: clinical, biochemical and molecular characterization of a new patient with severe phenotype and a novel mutation.
Blasi P; Palmerio F; Caldarola S; Rizzo C; Carrozzo R; Gibson KM; Novelletto A; Deodato F; Cappa M; Dioni-Vici C; Malaspina P
Clin Genet; 2006 Mar; 69(3):294-6. PubMed ID: 16542398
[No Abstract] [Full Text] [Related]
64. Studies on analogues of succinic semialdehyde as substrates for succinate semialdehyde dehydrogenase from rat brain.
Manzocchi A; Biondi P; Secchi C; Santaniello E
J Neurochem; 1986 Jun; 46(6):1895-8. PubMed ID: 3701337
[TBL] [Abstract][Full Text] [Related]
65. D-2-hydroxyglutaric aciduria in three patients with proven SSADH deficiency: genetic coincidence or a related biochemical epiphenomenon?
Struys EA; Verhoeven NM; Salomons GS; Berthelot J; Vianay-Saban C; Chabrier S; Thomas JA; Tsai AC; Gibson KM; Jakobs C
Mol Genet Metab; 2006 May; 88(1):53-7. PubMed ID: 16442322
[TBL] [Abstract][Full Text] [Related]
66. Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria).
Philippe A; Deron J; Geneviève D; de Lonlay P; Gibson KM; Rabier D; Munnich A
Dev Med Child Neurol; 2004 Aug; 46(8):564-8. PubMed ID: 15287248
[TBL] [Abstract][Full Text] [Related]
67. A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype.
Nylen K; Velazquez JL; Likhodii SS; Cortez MA; Shen L; Leshchenko Y; Adeli K; Gibson KM; Burnham WM; Snead OC
Exp Neurol; 2008 Apr; 210(2):449-57. PubMed ID: 18199435
[TBL] [Abstract][Full Text] [Related]
68. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
[TBL] [Abstract][Full Text] [Related]
69. Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats.
Sgaravatti AM; Sgarbi MB; Testa CG; Durigon K; Pederzolli CD; Prestes CC; Wyse AT; Wannmacher CM; Wajner M; Dutra-Filho CS
Neurochem Int; 2007 Feb; 50(3):564-70. PubMed ID: 17197055
[TBL] [Abstract][Full Text] [Related]
70. Glycine decarboxylase mutations: a distinctive phenotype of nonketotic hyperglycinemia in adults.
Dinopoulos A; Kure S; Chuck G; Sato K; Gilbert DL; Matsubara Y; Degrauw T
Neurology; 2005 Apr; 64(7):1255-7. PubMed ID: 15824356
[TBL] [Abstract][Full Text] [Related]
71. Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms.
Wu Y; Buzzi A; Frantseva M; Velazquez JP; Cortez M; Liu C; Shen L; Gibson KM; Snead OC
Ann Neurol; 2006 Jan; 59(1):42-52. PubMed ID: 16240371
[TBL] [Abstract][Full Text] [Related]
72. A unique mouse model for succinic semialdehyde dehydrogenase deficiency with implications for gamma hydroxybutyrate intoxication.
Peters H
Pharmacogenomics J; 2002; 2(1):3-4. PubMed ID: 11990378
[No Abstract] [Full Text] [Related]
73. [Canavan disease or N-acetyl aspartic aciduria: a case report].
Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
[TBL] [Abstract][Full Text] [Related]
74. Clinical aspects of the disorders of GABA metabolism in children.
Pearl PL; Gibson KM
Curr Opin Neurol; 2004 Apr; 17(2):107-13. PubMed ID: 15021235
[TBL] [Abstract][Full Text] [Related]
75. Functional characterization of a Drosophila melanogaster succinic semialdehyde dehydrogenase and a non-specific aldehyde dehydrogenase.
Rothacker B; Ilg T
Insect Biochem Mol Biol; 2008 Mar; 38(3):354-66. PubMed ID: 18252249
[TBL] [Abstract][Full Text] [Related]
76. Canavan disease: a review of recent developments.
Gordon N
Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
[TBL] [Abstract][Full Text] [Related]
77. Mitochondrial succinic-semialdehyde dehydrogenase of the gamma-aminobutyrate shunt is required to restrict levels of reactive oxygen intermediates in plants.
Bouché N; Fait A; Bouchez D; Møller SG; Fromm H
Proc Natl Acad Sci U S A; 2003 May; 100(11):6843-8. PubMed ID: 12740438
[TBL] [Abstract][Full Text] [Related]
78. Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency.
Jansen EE; Verhoeven NM; Jakobs C; Schulze A; Senephansiri H; Gupta M; Snead OC; Gibson KM
Biochim Biophys Acta; 2006 Apr; 1762(4):494-8. PubMed ID: 16504488
[TBL] [Abstract][Full Text] [Related]
79. N-acetylaspartic aciduria in Canavan disease: another proof in two infants.
Yalaz K; Topçu M; Topaloğlu H; Gürçay O; Ozcan OE; Onol B; Renda Y
Neuropediatrics; 1990 Aug; 21(3):140-2. PubMed ID: 2234319
[TBL] [Abstract][Full Text] [Related]
80. Gamma-hydroxybutyric aciduria: a biochemist's education from a heritable disorder of GABA metabolism.
Gibson KM
J Inherit Metab Dis; 2005; 28(3):247-65. PubMed ID: 15868461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]